Novanta Inc (NOVT) - Net Assets
Based on the latest financial reports, Novanta Inc (NOVT) has net assets worth $1.31 Billion USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.80 Billion) and total liabilities ($488.03 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Novanta Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.31 Billion |
| % of Total Assets | 72.87% |
| Annual Growth Rate | 9.24% |
| 5-Year Change | 152.12% |
| 10-Year Change | 407.7% |
| Growth Volatility | 38.34 |
Novanta Inc - Net Assets Trend (1998–2025)
This chart illustrates how Novanta Inc's net assets have evolved over time, based on quarterly financial data. See defensive interval ratio of Novanta Inc to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Novanta Inc (1998–2025)
The table below shows the annual net assets of Novanta Inc from 1998 to 2025. For live valuation and market cap data, see Novanta Inc stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $1.31 Billion | +76.25% |
| 2024-12-31 | $745.70 Million | +10.73% |
| 2023-12-31 | $673.46 Million | +16.60% |
| 2022-12-31 | $577.59 Million | +10.80% |
| 2021-12-31 | $521.29 Million | +9.33% |
| 2020-12-31 | $476.81 Million | +14.30% |
| 2019-12-31 | $417.17 Million | +13.28% |
| 2018-12-31 | $368.25 Million | +2.73% |
| 2017-12-31 | $358.47 Million | +38.47% |
| 2016-12-31 | $258.87 Million | +5.79% |
| 2015-12-31 | $244.70 Million | +15.83% |
| 2014-12-31 | $211.25 Million | -12.85% |
| 2013-12-31 | $242.40 Million | +6.22% |
| 2012-12-31 | $228.21 Million | +9.00% |
| 2011-12-31 | $209.36 Million | +158.10% |
| 2010-12-31 | $81.12 Million | -46.95% |
| 2009-12-31 | $152.90 Million | 0.00% |
| 2008-12-31 | $152.90 Million | -45.05% |
| 2007-12-31 | $278.24 Million | -18.90% |
| 2006-12-31 | $343.07 Million | +11.91% |
| 2005-12-31 | $306.56 Million | +0.32% |
| 2004-12-31 | $305.56 Million | +17.17% |
| 2003-12-31 | $260.79 Million | +2.48% |
| 2002-12-31 | $254.48 Million | -9.86% |
| 2001-12-31 | $282.33 Million | -2.40% |
| 2000-12-31 | $289.27 Million | +68.47% |
| 1999-12-31 | $171.70 Million | +42.02% |
| 1998-12-31 | $120.90 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Novanta Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1539.7% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $321.38 Million | 24.45% |
| Common Stock | $423.86 Million | 32.25% |
| Other Comprehensive Income | $-3.00 Million | -0.23% |
| Other Components | $572.06 Million | 43.53% |
| Total Equity | $1.31 Billion | 100.00% |
Novanta Inc Competitors by Market Cap
The table below lists competitors of Novanta Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Installed Building Products Inc
NYSE:IBP
|
$5.39 Billion |
|
Gecina SA
PA:GFC
|
$5.40 Billion |
|
Bausch + Lomb Corp
TO:BLCO
|
$5.40 Billion |
|
Vietnam Rubber Group Ltd
VN:GVR
|
$5.40 Billion |
|
Axcelis Technologies Inc
NASDAQ:ACLS
|
$5.39 Billion |
|
Casella Waste Systems Inc
NASDAQ:CWST
|
$5.39 Billion |
|
Jl Mag Rare-Earth Co Ltd Class A
SHE:300748
|
$5.39 Billion |
|
Hindustan Copper Limited
NSE:HINDCOPPER
|
$5.39 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Novanta Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 745,698,000 to 1,314,287,000, a change of 568,589,000 (76.2%).
- Net income of 53,829,000 contributed positively to equity growth.
- Share repurchases of 39,278,000 reduced equity.
- New share issuances of 614,390,000 increased equity.
- Other comprehensive income increased equity by 26,917,000.
- Other factors decreased equity by 87,269,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $53.83 Million | +4.1% |
| Share Repurchases | $39.28 Million | -2.99% |
| Share Issuances | $614.39 Million | +46.75% |
| Other Comprehensive Income | $26.92 Million | +2.05% |
| Other Changes | $-87.27 Million | -6.64% |
| Total Change | $- | 76.25% |
Book Value vs Market Value Analysis
This analysis compares Novanta Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.23x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 14.26x to 4.23x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1998-12-31 | $10.62 | $151.43 | x |
| 1999-12-31 | $16.92 | $151.43 | x |
| 2000-12-31 | $21.70 | $151.43 | x |
| 2001-12-31 | $20.99 | $151.43 | x |
| 2002-12-31 | $18.77 | $151.43 | x |
| 2003-12-31 | $19.16 | $151.43 | x |
| 2004-12-31 | $21.76 | $151.43 | x |
| 2005-12-31 | $21.97 | $151.43 | x |
| 2006-12-31 | $24.36 | $151.43 | x |
| 2007-12-31 | $26.32 | $151.43 | x |
| 2008-12-31 | $10.64 | $151.43 | x |
| 2009-12-31 | $10.62 | $151.43 | x |
| 2010-12-31 | $5.10 | $151.43 | x |
| 2011-12-31 | $6.22 | $151.43 | x |
| 2012-12-31 | $6.71 | $151.43 | x |
| 2013-12-31 | $7.04 | $151.43 | x |
| 2014-12-31 | $6.14 | $151.43 | x |
| 2015-12-31 | $7.03 | $151.43 | x |
| 2016-12-31 | $7.41 | $151.43 | x |
| 2017-12-31 | $8.83 | $151.43 | x |
| 2018-12-31 | $10.38 | $151.43 | x |
| 2019-12-31 | $11.74 | $151.43 | x |
| 2020-12-31 | $13.37 | $151.43 | x |
| 2021-12-31 | $14.57 | $151.43 | x |
| 2022-12-31 | $16.08 | $151.43 | x |
| 2023-12-31 | $18.69 | $151.43 | x |
| 2024-12-31 | $20.64 | $151.43 | x |
| 2025-12-31 | $35.81 | $151.43 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Novanta Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.10%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.49%
- • Asset Turnover: 0.54x
- • Equity Multiplier: 1.37x
- Recent ROE (4.10%) is above the historical average (-4.79%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1998 | -6.62% | -5.55% | 0.95x | 1.26x | $-20.09 Million |
| 1999 | -20.27% | -12.67% | 0.95x | 1.69x | $-51.97 Million |
| 2000 | 15.69% | 12.14% | 0.87x | 1.49x | $16.45 Million |
| 2001 | -5.21% | -5.93% | 0.74x | 1.19x | $-42.93 Million |
| 2002 | -10.89% | -17.43% | 0.54x | 1.17x | $-53.17 Million |
| 2003 | -0.83% | -1.17% | 0.60x | 1.18x | $-28.25 Million |
| 2004 | 13.57% | 12.57% | 0.85x | 1.26x | $10.91 Million |
| 2005 | 3.15% | 3.70% | 0.70x | 1.22x | $-21.00 Million |
| 2006 | 6.34% | 6.93% | 0.76x | 1.20x | $-12.56 Million |
| 2007 | 4.05% | 5.21% | 0.66x | 1.18x | $-22.26 Million |
| 2008 | -133.32% | -70.67% | 0.55x | 3.40x | $-219.14 Million |
| 2009 | -133.52% | -70.67% | 0.55x | 3.41x | $-219.11 Million |
| 2010 | -0.85% | -0.18% | 0.99x | 4.77x | $-8.80 Million |
| 2011 | 13.86% | 7.91% | 1.05x | 1.67x | $8.07 Million |
| 2012 | 8.58% | 7.20% | 0.80x | 1.48x | $-3.24 Million |
| 2013 | 3.02% | 2.14% | 0.90x | 1.57x | $-16.89 Million |
| 2014 | -11.50% | -6.65% | 0.92x | 1.89x | $-45.33 Million |
| 2015 | 14.55% | 9.53% | 0.90x | 1.70x | $11.14 Million |
| 2016 | 8.50% | 5.72% | 0.90x | 1.64x | $-3.88 Million |
| 2017 | 19.28% | 11.52% | 0.72x | 2.33x | $28.90 Million |
| 2018 | 13.34% | 7.99% | 0.85x | 1.95x | $12.28 Million |
| 2019 | 9.77% | 6.51% | 0.72x | 2.08x | $-944.20K |
| 2020 | 9.34% | 7.54% | 0.68x | 1.81x | $-3.16 Million |
| 2021 | 9.66% | 7.12% | 0.58x | 2.36x | $-1.80 Million |
| 2022 | 12.82% | 8.60% | 0.69x | 2.15x | $16.29 Million |
| 2023 | 10.82% | 8.27% | 0.72x | 1.82x | $5.53 Million |
| 2024 | 8.59% | 6.75% | 0.68x | 1.86x | $-10.48 Million |
| 2025 | 4.10% | 5.49% | 0.54x | 1.37x | $-77.60 Million |
Industry Comparison
This section compares Novanta Inc's net assets metrics with peer companies in the Scientific & Technical Instruments industry.
Industry Context
- Industry: Scientific & Technical Instruments
- Average net assets among peers: $153,184,272
- Average return on equity (ROE) among peers: 4.28%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Novanta Inc (NOVT) | $1.31 Billion | -6.62% | 0.37x | $5.39 Billion |
| Acorn Energy, Inc. Common Stock (ACFN) | $8.32 Million | 30.18% | 0.60x | $40.70 Million |
| Ainos Inc (AIMD) | $-4.78 Million | 0.00% | 0.00x | $12.35 Million |
| Arrive AI Inc. (ARAI) | $3.16 Million | -48.32% | 0.02x | $24.81 Million |
| Arbe Robotics Ltd (ARBE) | $-4.72 Million | 0.00% | 0.00x | $103.16 Million |
| Astrotech Corp (ASTC) | $102.70 Million | -3.74% | 1.19x | $4.87 Million |
| Badger Meter Inc (BMI) | $111.02 Million | 22.59% | 0.76x | $3.81 Billion |
| Cognex Corporation (CGNX) | $14.30 Million | 25.87% | 0.27x | $10.20 Billion |
| Coherent Inc (COHR) | $900.56 Million | 10.58% | 0.64x | $65.59 Billion |
| Electro-Sensors Inc (ELSE) | $10.38 Million | 5.28% | 0.15x | $26.95 Million |
| ESCO Technologies Inc (ESE) | $390.90 Million | 0.36% | 0.39x | $7.89 Billion |
About Novanta Inc
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets la… Read more